Literature DB >> 26263367

Cannabinoid receptor agonist namisol does not affect cytokine levels in chronic pancreatitis patients.

Wesley K Utomo1, Marjan de Vries2, Dagmar C van Rijckevorsel2, Maikel P Peppelenbosch1, Harry van Goor2, Gwenny M Fuhler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26263367     DOI： 10.1038/ajg.2015.197

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  2 in total

1.  Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.

Authors:  Linda E Klumpers; Tim L Beumer; Johan G C van Hasselt; Astrid Lipplaa; Lennard B Karger; H Daniël Kleinloog; Jan I Freijer; Marieke L de Kam; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

Review 2.  Medical marijuana for digestive disorders: high time to prescribe?

Authors:  Mark E Gerich; Robert W Isfort; Bryan Brimhall; Corey A Siegel
Journal:  Am J Gastroenterol       Date:  2014-09-09       Impact factor: 10.864
  2 in total
  4 in total

1.  Response to Utomo et al.

Authors:  Robert W Isfort; Colm B Collins; Mark E Gerich
Journal:  Am J Gastroenterol       Date:  2015-08       Impact factor: 10.864

2.  Severity and outcomes of acute alcoholic pancreatitis in cannabis users.

Authors:  Hemant Goyal; Kelsey Guerreso; Betsy Smith; Kaitlin Harper; Sheetal Patel; Akash Patel; Puja Parikh
Journal:  Transl Gastroenterol Hepatol       Date:  2017-07-21

Review 3.  Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports.

Authors:  Camille Azam; Louis Buscail; Adrian Culetto; Maryse Lapeyre-Mestre
Journal:  Drug Saf       Date:  2022-02-18       Impact factor: 5.606

4.  Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids.

Authors:  Wesley K Utomo; Marjan de Vries; Henri Braat; Marco J Bruno; Kaushal Parikh; Mònica Comalada; Maikel P Peppelenbosch; Harry van Goor; Gwenny M Fuhler
Journal:  Front Mol Neurosci       Date:  2017-01-24       Impact factor: 5.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.